Vorsitz: D. Hilfiker-Kleiner (Hannover), L. S. Maier (Göttingen)
(V533) | Rapid progression of pressure overload-induced cardiac hypertrophy to heart failure in mice with a human CPVT mutation |
|
S. Sedej, S. Walther, A. Schmidt, E. Bisping, F. R. Heinzel, S. G. Priori, J. Kockskämper, B. Pieske on behalf of CONTICA (Graz, AT; Pavia, IT) |
(V534) | Influence of biglycan on cardiac fibrosis during left ventricular pressure overload |
|
N. Beetz, E. Volodko, B. Rylski, F. Beyersdorf, J. W. Fischer, L. Hein (Freiburg im Breisgau, Essen) |
(V535) | AKT- Blockade aggraviert pathologische und inhibiert physiologische Hypertrophie |
|
J. Riffel, S. Buß, M. Hagenmüller, C. Weiss, H. A. Katus, S. Hardt (Heidelberg) |
(V536) | Pressure Overload – Induced Hypertrophy is Linked to an Increase in Mitochondrial ROS – Production |
|
A. Lunkenbein, P. A. Amorim, A. Schrepper, M. Schwarzer, F. W. Mohr, T. Doenst (Leipzig) |
(V537) | SDF-1/CXCR4-signaling contributes to myocardial remodeling |
|
S. Bettink, K. Walenta, M. Böhm, U. Laufs, E. Friedrich (Homburg/Saar) |
(V538) | Significance of Methyl-CpG-binding protein 2 during the development of cardiac hypertrophy in mice |
|
S. Weiß, R. Gilsbach, H. Linhart, L. Hein (Freiburg im Breisgau, Heidelberg) |